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Introduction
Yolk sac tumors (YSTs) are the most common testicular tumors occurring in children younger than 3 years of age and are also known as endodermal sinus tumors. Extragonadal YSTs are rare, and adult onset is uncommon. YST lesions produce several tumor markers, including alphafetoprotein (AFP) and human chorionic gonadotropin (HCG) beta. Protein induced by vitamin K absence or antagonist-II (PIVKA-II), also known as des-gamma-carboxy prothrombin, is a specific tumor marker for hepatocellular carcinoma (HCC) (1) . No cases of PIVKA-II-producing YSTs have been previously reported in the literature. We herein report a case of a PIVKA-II-producing extragonadal YST.
Case Report
A 66-year-old Japanese man was admitted to Sapporo Shirakaba-dai Hospital with a cough, fever and chest pain. He had been under treatment for hypertension, diabetes mellitus and hyperlipidemia. A physical examination revealed only anemic conjunctiva, while the laboratory findings on admission showed anemia (hemoglobin, 8.3 g/dL), thrombocytopenia (72×10 9 /L), hypoalbuminemia (2.9 mg/dL) and liver dysfunction (serum aspartate aminotransferase, 63 U/L; lactate dehydrogenase, 42 U/L; gamma-glutamyl transpeptidase, 65 IU/L). Several tumor markers were elevated, including the following: AFP, 15,432 ng/mL; PIVKA-II, 14,161 mAU/mL; carcinoembryonic antigen, 10.6 ng/mL; CA19-9, 42 U/mL; HCG beta, 0.2 ng/mL; and neuronspecific enolase, 21.9 ng/mL. However, other parameters were normal: squamous cell carcinoma antigen (SCC), 0.9 ng/mL; pro-gastrin releasing peptide (ProGRP), 8.3 pg/dL; and Cypra, 1.2 ng/mL. Serological studies for hepatitis B and C viruses were negative. However, chest computed tomography (CT) disclosed multiple tumors in the lungs, mediastinum and hilus, and abdominal CT demonstrated a mas- sively enlarged tumor measuring 120 mm in size in the right lobe of the liver. Triple-phase enhanced CT showed no staining in the mass during the arterial phase, which indicated that the tumor was not typical HCC ( Fig. 1 ). Meanwhile, CT revealed thrombosis in both the anterior portal vein and inferior vena cava in the portal phase. Although these data suggested a diagnosis of HCC, several findings, including the presence of mediastinal and hilar masses and the unusual enhanced CT features indicated the possibility of atypical HCC or another malignancy. The patient was thus transferred to Sapporo Medical University Hospital for further diagnosis and treatment. A positron emission tomography study with 18F-fluorodeoxyglucose showed extensive uptake in the intrapleural and liver masses, and an echo-guided percutaneous needle biopsy disclosed reticularly arranged tumor cell nests consisting of large cells with moderate to ample cytoplasm and a large nucleus in association with liver cirrhosis. Immunohistochemistry subsequently demonstrated that the tumor cells expressed AFP, glypican-3, PIVKA-II and Sal-like protein 4 (SALL4) but neither hepatocyte paraffin-1 (HepPar1) nor arginine-1 (Fig. 2) . In contrast, CD10 stained all tumor cells diffusely, which is quite different from the pericanalicular staining pattern sometimes noted in cases of well-differentiated HCC. In addition to the histological features, these data strongly suggested that the tumor should be diagnosed as YST, not HCC. Therefore, the patient was treated with intensive chemotherapy using the BEP regimen (bleomycin: 30 mg/body, days 1, 8 and 15; etoposide: 100 mg/m 2 , days 1-5; cisplatin: 20 mg/m 2 , days 1-5). After the completion of chemotherapy, the size of the tumor clearly diminished and the concentrations of both AFP and PIVKA-II decreased to 415.3 ng/mL and 1,158 mAU/mL, respectively. However, the patient's bone marrow was severely suppressed, and he consequently developed pneumonia followed by sepsis. He ultimately died of respiratory failure, and an autopsy was performed.
The autopsy revealed that the main mediastinal tumor had disappeared and the liver mass had shrunk to 45×35 mm. In addition, there were lymph nodes of different sizes in the mediastinum and around the stomach. A histopathological examination revealed a limited number of YST cells with a large amount of necrosis and hemorrhage in both the mediastinal and perigastric lymph nodes as well as several lung nodules. The hepatic mass, which consisted of YST cells and necrotic tissue, was surrounded by fibrosis. Furthermore, most of the tumor area exhibited a solid pattern of pleomorphic tumor cells, although other tumor regions exhibited an endodermal sinus pattern with Schiller-Duval body-like pseudopapillary structures ( Fig. 3 ). An immunohistochemical examination again showed that the tumor cells expressed AFP, PIVKA-II, glypican-3, SALL4 and CD10 (diffuse pattern) but not HepPar1 or arginase-1. The absence of OCT3/4, D2-40, c-kit and CD30 ruled out the presence of other germ cell tumors (GCTs), such as germinoma and embryonal carcinoma. No hepatoid component was identified histologically or immunohistochemically. Moreover, the autopsy revealed no tumors in the testicles. Finally, the tumor was confirmed to be an AFP-and PIVKA-II-producing 
Discussion
YST is a nonseminomatous GCT resembling saccus vitel-linus of the fetus. Most GCTs occur inside the gonads; however, 2-5% of GCTs are of extragonadal origin (2). Fiftyfour percent of extragonadal GCTs occur in the mediastinum, with 45% in the retroperitoneum (3). Nonseminomatous GCT is often invasive and includes locally advanced or In this report, we presented the case of an elderly man with a massive tumor in the liver associated with high concentrations of AFP and PIVKA-II. Although the possibility of HCC was considered during the differential diagnosis, scans of the mediastinal masses showed atypical features, thus ruling out the possibility that the tumors were metastatic HCC. Nonseminomatous GCT appears radiographically as a large lobulated mediastinal mass with either a wellcircumscribed or irregular margin. CT images usually show heterogeneous masses with central hypodense regions corresponding to areas of hemorrhage or necrosis. Peripheral enhancement of the tumor is observed following the admin istration of contrast material, and the interface between the tumor and the adjacent lung tissue may be irregular and/or spiculated due to invasion (5). These features were detected in the current case.
Histological and immunohistochemical investigations of the tumor samples obtained via both biopsy and autopsy in this case demonstrated that the tumor was YST, not HCC. In addition, the tumor cells produced SALL4, GLP3, AFP and PIVKA-II, whereas hepatocyte-specific markers, including HepPar-1 and arginase-1, were absent. Furthermore, the tumor did not show hepatoid differentiation, as indicated by the absence of an oncocytic morphology with a trabecular pattern and bile production with canalicular differentiation visualized with CD10. In addition, the tumor exhibited an endodermal sinus pattern characterized by the presence of Schiller-Duval body-like pseudopapillary structures with solid tumor cell nests. These findings support an origin of YST in this case.
Although PIVKA-II is considered to be a more specific marker for HCC than AFP (6), malignant tumors other than HCC seldom produce PIVKA-II. A Medline search (Table) identified 22 cases of PIVKA-II-producing tumors other than HCC (7-28), with 15 tumors detected in the stomach (7-21). Nineteen of the 22 cases were immunohistochemically positive for PIVKA-II, and 21 involved high serum levels of AFP. Although hepatoid differentiation was histologically confirmed in 12 tumors, nine cases did not include hepatoid segments. Clinically, 13 patients had multiple liver metastases, and 10 patients died within six months of diagnosis. A case of mediastinal embryonal carcinoma with features of hepatoid differentiation was also reported (28) .
The mechanism of PIVKA-II production in this type of tumor is unknown. It has been shown that the hepatoid foci of gastric adenocarcinoma produce both AFP and PIVKA-II (7). As the foregut endoblasts form the yolk sac and liver, hepatoid differentiation of YST is not unusual (29) , detected in 9.3% of GCTs (30) . As mentioned earlier, PIVKA-IIproducing gastric cancer cases without a hepatoid segment have been reported (16) . Although such hepatoid differentiation is identified based on morphological characteristics and/ or immunostaining with AFP and PIVKA-II, the levels of hepatocyte markers, including arginase-1 and HepPar1, have not been examined in previous reports. In the present study, we demonstrated that the tumor did not display hepatocyte differentiation, as indicated on histopathology and immunohistochemistry, although it did produce PIVKA-II together with AFP and GLP-3 oncofetal proteins. Hence, it can be speculated based on the findings of the present study that YST produces PIVKA-II without hepatoid differentiation. One reason why PIVKA-II-producing YST has not been previously reported may be that the PIVKA-II expression is seldom measured in patients with YST. In this regard, there is an interesting report, written in Japanese and not listed in Medline, of a case of YST arising from gastric adenocarcinoma with high serum levels of both AFP and PIVKA-II (31) . Therefore, it is important to examine the PIVKA-II expression in cases of YST in the future.
BEP therapy, recommended chemotherapy for GCTs, including YSTs, was very effective in this case, as demonstrated by the marked reductions in the main mediastinal tumor volume and serum levels of PIVKA-II and AFP. As BEP is not a mandatory chemotherapeutic modality for HCC, the effectiveness of BEP treatment in this case again supports a diagnosis of YST rather than HCC.
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